SLT is a cost-effective, first-line glaucoma approach

Dr. Nate Radcliffe shares how Lumenis SLT is a cost-effective first-line approach for patients with glaucoma in this video from ASCRS San Diego.

READ FULL ARTICLE

Nathan M. Radcliffe, MD

Explore Other Resources

Dry EyePeriorbital Muscle StimulationPress PublicationsPress ReleasesTreatment TypeVision Resource Hub
Dry EyePeriorbital Muscle StimulationPress PublicationsPress ReleasesTreatment TypeVision Resource Hub

Behind OptiLIFT’s Lid Laxity Innovation

READ MORE

    PB-00038930 Rev A